menu ☰
menu ˟

Balloon-expandable TAVR system approved for intermediate-risk patients in Europe

25 Sep 2016
Edwards Lifesciences announced its newest-generation balloon-expandable transcatheter aortic valve replacement system, has received a CE mark to extend its use for patients with severe aortic stenosis at intermediate risk for surgery.The valve (Sapie...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.